JEANNE VAN EEPOEL: Open Payments
NPI 1457659021 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,399 in 114 payments from 15 companies in 2025. Trend: 2023 $100 · 2024 $2,288 · 2025 $2,399
Food & beverage: $2,399
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $360 |
| ABBVIE INC. | 20 | $348 |
| Otsuka America Pharmaceutical, Inc. | 10 | $275 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $240 |
| Axsome Therapeutics, Inc. | 17 | $238 |
| Teva Pharmaceuticals USA, Inc. | 13 | $220 |
| Supernus Pharmaceuticals, Inc. | 6 | $173 |
| Vanda Pharmaceuticals Inc. | 8 | $150 |
| Neurocrine BioSciences, Inc. | 6 | $124 |
| Alkermes, Inc. | 5 | $88 |
Products named: COBENFY, VRAYLAR, REXULTI, CAPLYTA, Auvelity, AUSTEDO XR, Qelbree, FANAPT.
Industry payments across FL — which companies pay providers there.
